Oxford Biodynamics Plc - Product Pipeline Analysis, 2018 Update

Products Id :- GDME375293PD
|
Pages: 64
|
September 2018
|
Region: Europe
|

Request for Sample Report

Request A Quote

Executive Summary

Summary

Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The company's products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, Oxfordshire, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Oxford Biodynamics Plc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Oxford Biodynamics Plc Company Overview 6

Oxford Biodynamics Plc Company Snapshot 6

Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview 6

Oxford Biodynamics Plc-Pipeline Analysis Overview 9

Oxford Biodynamics Plc-Key Facts 9

Oxford Biodynamics Plc-Major Products and Services 10

Oxford Biodynamics Plc Pipeline Products by Development Stage 11

Oxford Biodynamics Plc Pipeline Products Overview 16

Companion Diagnostic Test-Amyotrophic Lateral Sclerosis 16

Companion Diagnostic Test-Amyotrophic Lateral Sclerosis Product Overview 16

Companion Diagnostic Test-Corticobasal Degeneration 17

Companion Diagnostic Test-Corticobasal Degeneration Product Overview 17

Companion Diagnostic Test-Dementia With Lewy Bodies 18

Companion Diagnostic Test-Dementia With Lewy Bodies Product Overview 18

Companion Diagnostic Test-Diffuse Lewy Body Disease 19

Companion Diagnostic Test-Diffuse Lewy Body Disease Product Overview 19

Companion Diagnostic Test-Frontotemporal Lobar Degeneration 20

Companion Diagnostic Test-Frontotemporal Lobar Degeneration Product Overview 20

Companion Diagnostic Test-Multiple System Atrophy 21

Companion Diagnostic Test-Multiple System Atrophy Product Overview 21

Companion Diagnostic Test-Osteoporosis 22

Companion Diagnostic Test-Osteoporosis Product Overview 22

Companion Diagnostic Test-Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex 23

Companion Diagnostic Test-Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex Product Overview 23

Companion Diagnostic Test-Progressive Supranuclear Palsy 24

Companion Diagnostic Test-Progressive Supranuclear Palsy Product Overview 24

Companion Diagnostic Test-Sarcopenia 25

Companion Diagnostic Test-Sarcopenia Product Overview 25

EpiSwitch Alzheimer's Disease Diagnostic Test 26

EpiSwitch Alzheimer's Disease Diagnostic Test Product Overview 26

EpiSwitch Biomarker-Concussion 27

EpiSwitch Biomarker-Concussion Product Overview 27

EpiSwitch Breast Cancer Test 28

EpiSwitch Breast Cancer Test Product Overview 28

EpiSwitch Diagnostic Assay-Amyotrophic Lateral Sclerosis 29

EpiSwitch Diagnostic Assay-Amyotrophic Lateral Sclerosis Product Overview 29

EpiSwitch Diffuse Large B-Cell Lymphoma Test 30

EpiSwitch Diffuse Large B-Cell Lymphoma Test Product Overview 30

EpiSwitch Liver Cancer Test 31

EpiSwitch Liver Cancer Test Product Overview 31

EpiSwitch Melanoma Companion Diagnostic Assay 32

EpiSwitch Melanoma Companion Diagnostic Assay Product Overview 32

EpiSwitch Melanoma Test 33

EpiSwitch Melanoma Test Product Overview 33

EpiSwitch Melanoma Test-Prognosis 34

EpiSwitch Melanoma Test-Prognosis Product Overview 34

EpiSwitch Melanoma Test-Residual Disease Monitoring 35

EpiSwitch Melanoma Test-Residual Disease Monitoring Product Overview 35

EpiSwitch Nasopharyngeal Cancer Test 36

EpiSwitch Nasopharyngeal Cancer Test Product Overview 36

EpiSwitch Parkinson's Disease Diagnostic Test 37

EpiSwitch Parkinson's Disease Diagnostic Test Product Overview 37

EpiSwitch Primary Progressive Multiple Sclerosis Test 38

EpiSwitch Primary Progressive Multiple Sclerosis Test Product Overview 38

EpiSwitch Prognostic Assay-Amyotrophic Lateral Sclerosis 39

EpiSwitch Prognostic Assay-Amyotrophic Lateral Sclerosis Product Overview 39

EpiSwitch Prognostic Assay-Tyrosine Kinase Inhibitors 40

EpiSwitch Prognostic Assay-Tyrosine Kinase Inhibitors Product Overview 40

EpiSwitch Prostate Cancer Prognostic Assay 41

EpiSwitch Prostate Cancer Prognostic Assay Product Overview 41

EpiSwitch Prostate Cancer Test 42

EpiSwitch Prostate Cancer Test Product Overview 42

EpiSwitch Relapsing Remitting Multiple Sclerosis Test 43

EpiSwitch Relapsing Remitting Multiple Sclerosis Test Product Overview 43

EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test 44

EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test Product Overview 44

EpiSwitch Systemic Lupus Erythematosus Prognostic Test 45

EpiSwitch Systemic Lupus Erythematosus Prognostic Test Product Overview 45

EpiSwitch T1DM Diagnostic Test 46

EpiSwitch T1DM Diagnostic Test Product Overview 46

EpiSwitch T1DM Prognostic Test 47

EpiSwitch T1DM Prognostic Test Product Overview 47

EpiSwitch T2DM Prognostic Test 48

EpiSwitch T2DM Prognostic Test Product Overview 48

EpiSwitch Thyroid Cancer Diagnostic Test 49

EpiSwitch Thyroid Cancer Diagnostic Test Product Overview 49

EpiSwitch Ulcerative Colitis Test 50

EpiSwitch Ulcerative Colitis Test Product Overview 50

Oxford Biodynamics Plc-Key Competitors 51

Oxford Biodynamics Plc-Key Employees 52

Oxford Biodynamics Plc-Locations And Subsidiaries 53

Head Office 53

Other Locations & Subsidiaries 53

Recent Developments 54

Oxford Biodynamics Plc, Recent Developments 54

Jul 19, 2018: Oxford BioDynamics announces grant of Canadian patent for its proprietary technology platform, EpiSwitch 54

Jul 17, 2018: OBD presents latest data on the use of EpiSwitch in predicting patient response to immunotherapy and identifying lymphoma subtypes 54

Jun 26, 2018: Study published in peer reviewed journal identifies EpiSwitch biomarker for the diagnosis of Amyotrophic Lateral Sclerosis 55

May 22, 2018: Oxford Biodynamics: Interim Results For The Six-Month Period Ended 31 March 2018 55

Mar 28, 2018: Study published in Journal of Translational Medicine demonstrates predictive power of EpiSwitch to identify inadequate response to methotrexate in early rheumatoid arthritis 56

Mar 16, 2018: OBD presents latest ALS biomarker data at the 6th World CNS Summit (Targeting Neurodegenerative Diseases) 57

Feb 14, 2018: Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch 58

Nov 15, 2017: Oxford BioDynamics presents latest immunotherapy data at the NIH Biomarker Consortium Cancer Steering Committee Annual Symposium, in Washington, DC 58

Oct 13, 2017: Oxford BioDynamics presents at the Diabetes Asia 2017 Conference 59

Oct 13, 2017: Oxford BioDynamics presents at the Diabetes Asia 2017 Conference 60

Appendix 61

Methodology 61

About GlobalData 64

Disclaimer 64

List of Figures

Oxford Biodynamics Plc Pipeline Products by Equipment Type 7

Oxford Biodynamics Plc Pipeline Products by Development Stage 11

List of Tables

Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview 6

Oxford Biodynamics Plc Pipeline Products by Equipment Type 7

Oxford Biodynamics Plc Pipeline Products by Indication 8

Oxford Biodynamics Plc, Key Facts 9

Oxford Biodynamics Plc, Major Products and Services 10

Oxford Biodynamics Plc Number of Pipeline Products by Development Stage 11

Oxford Biodynamics Plc Pipeline Products Summary by Development Stage 12

Companion Diagnostic Test-Amyotrophic Lateral Sclerosis-Product Status 16

Companion Diagnostic Test-Amyotrophic Lateral Sclerosis-Product Description 16

Companion Diagnostic Test-Corticobasal Degeneration-Product Status 17

Companion Diagnostic Test-Corticobasal Degeneration-Product Description 17

Companion Diagnostic Test-Dementia With Lewy Bodies-Product Status 18

Companion Diagnostic Test-Dementia With Lewy Bodies-Product Description 18

Companion Diagnostic Test-Diffuse Lewy Body Disease-Product Status 19

Companion Diagnostic Test-Diffuse Lewy Body Disease-Product Description 19

Companion Diagnostic Test-Frontotemporal Lobar Degeneration-Product Status 20

Companion Diagnostic Test-Frontotemporal Lobar Degeneration-Product Description 20

Companion Diagnostic Test-Multiple System Atrophy-Product Status 21

Companion Diagnostic Test-Multiple System Atrophy-Product Description 21

Companion Diagnostic Test-Osteoporosis-Product Status 22

Companion Diagnostic Test-Osteoporosis-Product Description 22

Companion Diagnostic Test-Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex-Product Status 23

Companion Diagnostic Test-Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex-Product Description 23

Companion Diagnostic Test-Progressive Supranuclear Palsy-Product Status 24

Companion Diagnostic Test-Progressive Supranuclear Palsy-Product Description 24

Companion Diagnostic Test-Sarcopenia-Product Status 25

Companion Diagnostic Test-Sarcopenia-Product Description 25

EpiSwitch Alzheimer's Disease Diagnostic Test-Product Status 26

EpiSwitch Alzheimer's Disease Diagnostic Test-Product Description 26

EpiSwitch Biomarker-Concussion-Product Status 27

EpiSwitch Biomarker-Concussion-Product Description 27

EpiSwitch Breast Cancer Test-Product Status 28

EpiSwitch Breast Cancer Test-Product Description 28

EpiSwitch Diagnostic Assay-Amyotrophic Lateral Sclerosis-Product Status 29

EpiSwitch Diagnostic Assay-Amyotrophic Lateral Sclerosis-Product Description 29

EpiSwitch Diffuse Large B-Cell Lymphoma Test-Product Status 30

EpiSwitch Diffuse Large B-Cell Lymphoma Test-Product Description 30

EpiSwitch Liver Cancer Test-Product Status 31

EpiSwitch Liver Cancer Test-Product Description 31

EpiSwitch Melanoma Companion Diagnostic Assay-Product Status 32

EpiSwitch Melanoma Companion Diagnostic Assay-Product Description 32

EpiSwitch Melanoma Test-Product Status 33

EpiSwitch Melanoma Test-Product Description 33

EpiSwitch Melanoma Test-Prognosis-Product Status 34

EpiSwitch Melanoma Test-Prognosis-Product Description 34

EpiSwitch Melanoma Test-Residual Disease Monitoring-Product Status 35

EpiSwitch Melanoma Test-Residual Disease Monitoring-Product Description 35

EpiSwitch Nasopharyngeal Cancer Test-Product Status 36

EpiSwitch Nasopharyngeal Cancer Test-Product Description 36

EpiSwitch Parkinson's Disease Diagnostic Test-Product Status 37

EpiSwitch Parkinson's Disease Diagnostic Test-Product Description 37

EpiSwitch Primary Progressive Multiple Sclerosis Test-Product Status 38

EpiSwitch Primary Progressive Multiple Sclerosis Test-Product Description 38

EpiSwitch Prognostic Assay-Amyotrophic Lateral Sclerosis-Product Status 39

EpiSwitch Prognostic Assay-Amyotrophic Lateral Sclerosis-Product Description 39

EpiSwitch Prognostic Assay-Tyrosine Kinase Inhibitors-Product Status 40

EpiSwitch Prognostic Assay-Tyrosine Kinase Inhibitors-Product Description 40

EpiSwitch Prostate Cancer Prognostic Assay-Product Status 41

EpiSwitch Prostate Cancer Prognostic Assay-Product Description 41

EpiSwitch Prostate Cancer Test-Product Status 42

EpiSwitch Prostate Cancer Test-Product Description 42

EpiSwitch Relapsing Remitting Multiple Sclerosis Test-Product Status 43

EpiSwitch Relapsing Remitting Multiple Sclerosis Test-Product Description 43

EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test-Product Status 44

EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test-Product Description 44

EpiSwitch Systemic Lupus Erythematosus Prognostic Test-Product Status 45

EpiSwitch Systemic Lupus Erythematosus Prognostic Test-Product Description 45

EpiSwitch T1DM Diagnostic Test-Product Status 46

EpiSwitch T1DM Diagnostic Test-Product Description 46

EpiSwitch T1DM Prognostic Test-Product Status 47

EpiSwitch T1DM Prognostic Test-Product Description 47

EpiSwitch T2DM Prognostic Test-Product Status 48

EpiSwitch T2DM Prognostic Test-Product Description 48

EpiSwitch Thyroid Cancer Diagnostic Test-Product Status 49

EpiSwitch Thyroid Cancer Diagnostic Test-Product Description 49

EpiSwitch Ulcerative Colitis Test-Product Status 50

EpiSwitch Ulcerative Colitis Test-Product Description 50

Oxford Biodynamics Plc, Key Employees 52

Oxford Biodynamics Plc, Other Locations 53

Glossary 63

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

LGC Ltd

InHealth

Almac Discovery Ltd

Aktogen Ltd

ABS Laboratories Ltd

Oxford Biodynamics Plc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

Oxford Biodynamics Plc - Product Pipeline Analysis, 2018 Update

The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"

Wish to Know more

download

For Further Enquiry

apply for job

Know how We Roll

Engage with Us